Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage DecisionRosita van den Puttelaar, Iris Lansdorp‐Vogelaar, Pedro Nascimento de Lima et al.|Gastroenterology|2024Cited by 62
Characteristics of a cost-effective blood test for colorectal cancer screeningPedro Nascimento de Lima, Carolyn M. Rutter, Nicholson Collier et al.|JNCI Journal of the National Cancer Institute|2024Cited by 26
Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemicPedro Nascimento de Lima, Carolyn M. Rutter, Rosita van den Puttelaar et al.|eLife|2023Cited by 21
Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer ScreeningDavid A. Lieberman, Rosita van den Puttelaar, Aasma Shaukat et al.|Clinical Gastroenterology and Hepatology|2024Cited by 17
NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling StudyD Berg, Lucie de Jonge, Pedro Nascimento de Lima et al.|Gastroenterology|2023Cited by 12